Priebe W - Search Results

1

Cellular pharmacology of the partially non-cross-resistant anthracycline annamycin entrapped in liposomes in KB and KB-V1 cells.

Perez-Soler R, Ling YH, Zou Y, Priebe W. Perez-Soler R, et al. Among authors: priebe w. Cancer Chemother Pharmacol. 1994;34(2):109-18. doi: 10.1007/BF00685927. Cancer Chemother Pharmacol. 1994. PMID: 8194162

2

Liposomal formulation and antitumor activity of 14-O-palmitoyl-hydroxyrubicin.

Perez-Soler R, Priebe W. Perez-Soler R, et al. Among authors: priebe w. Cancer Chemother Pharmacol. 1992;30(4):267-71. doi: 10.1007/BF00686293. Cancer Chemother Pharmacol. 1992. PMID: 1643693

3

Anthracycline antibiotics with high liposome entrapment: structural features and biological activity.

Perez-Soler R, Priebe W. Perez-Soler R, et al. Among authors: priebe w. Cancer Res. 1990 Jul 15;50(14):4260-6. Cancer Res. 1990. PMID: 2194651

4

Partial circumvention of multi-drug resistance by annamycin is associated with comparable inhibition of DNA synthesis in the nuclear matrix of sensitive and resistant cells.

Ling YH, Zou Y, Priebe W, Perez-Soler R. Ling YH, et al. Among authors: priebe w. Int J Cancer. 1995 May 4;61(3):402-8. doi: 10.1002/ijc.2910610321. Int J Cancer. 1995. PMID: 7729954

5

Effect of vesicle size and lipid composition on the in vivo tumor selectivity and toxicity of the non-cross-resistant anthracycline annamycin incorporated in liposomes.

Zou Y, Ling YH, Reddy S, Priebe W, Perez-Soler R. Zou Y, et al. Among authors: priebe w. Int J Cancer. 1995 May 29;61(5):666-71. doi: 10.1002/ijc.2910610513. Int J Cancer. 1995. PMID: 7768640

6

Hydroxyrubicin, a deaminated derivative of doxorubicin, inhibits mammalian DNA topoisomerase II and partially circumvents multidrug resistance.

Solary E, Ling YH, Perez-Soler R, Priebe W, Pommier Y. Solary E, et al. Among authors: priebe w. Int J Cancer. 1994 Jul 1;58(1):85-94. doi: 10.1002/ijc.2910580115. Int J Cancer. 1994. PMID: 8014019

7

Design and tumor targeting of anthracyclines able to overcome multidrug resistance: a double-advantage approach.

Priebe W, Perez-Soler R. Priebe W, et al. Pharmacol Ther. 1993 Nov;60(2):215-34. doi: 10.1016/0163-7258(93)90007-z. Pharmacol Ther. 1993. PMID: 8022858 Review.

8

Antitumor activity of free and liposome-entrapped annamycin, a lipophilic anthracycline antibiotic with non-cross-resistance properties.

Zou Y, Ling YH, Van NT, Priebe W, Perez-Soler R. Zou Y, et al. Among authors: priebe w. Cancer Res. 1994 Mar 15;54(6):1479-84. Cancer Res. 1994. PMID: 8137251

9

Quantitative analysis of the lipophilic doxorubicin analogue annamycin in plasma and tissue samples by reversed-phase chromatography.

Zou Y, Hayman A, Priebe W, Perez-Soler R. Zou Y, et al. Among authors: priebe w. J Pharm Sci. 1993 Nov;82(11):1151-4. doi: 10.1002/jps.2600821117. J Pharm Sci. 1993. PMID: 8289131

10

In vitro cytotoxicity, cellular pharmacology, and DNA lesions induced by annamycin, an anthracycline derivative with high affinity for lipid membranes.

Ling YH, Priebe W, Yang LY, Burke TG, Pommier Y, Perez-Soler R. Ling YH, et al. Among authors: priebe w. Cancer Res. 1993 Apr 1;53(7):1583-9. Cancer Res. 1993. PMID: 8453627

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

206 results

Search Page

Filters